Engineering precision nanoparticles for drug delivery
Michael J. Mitchell,Margaret M. Billingsley,Rebecca M Haley,Marissa E. Wechsler,Nicholas A. Peppas,Robert Langer +5 more
Reads0
Chats0
TLDR
Advances in nanoparticle design that overcome heterogeneous barriers to delivery are discussed, arguing that intelligent nanoparticles design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.Abstract:
In recent years, the development of nanoparticles has expanded into a broad range of clinical applications. Nanoparticles have been developed to overcome the limitations of free therapeutics and navigate biological barriers - systemic, microenvironmental and cellular - that are heterogeneous across patient populations and diseases. Overcoming this patient heterogeneity has also been accomplished through precision therapeutics, in which personalized interventions have enhanced therapeutic efficacy. However, nanoparticle development continues to focus on optimizing delivery platforms with a one-size-fits-all solution. As lipid-based, polymeric and inorganic nanoparticles are engineered in increasingly specified ways, they can begin to be optimized for drug delivery in a more personalized manner, entering the era of precision medicine. In this Review, we discuss advanced nanoparticle designs utilized in both non-personalized and precision applications that could be applied to improve precision therapies. We focus on advances in nanoparticle design that overcome heterogeneous barriers to delivery, arguing that intelligent nanoparticle design can improve efficacy in general delivery applications while enabling tailored designs for precision applications, thereby ultimately improving patient outcome overall.read more
Citations
More filters
Journal ArticleDOI
Peculiar Size Effects in Nanoscaled Systems
Maaza Malik,M. Henini,FI Ezema,E. Manikandan,John Kennedy,Kh. Bouziane,M. Chaker,Alain Gibaud,A.K.F. Haque,Z.Y. Nuru,I. Ahmad,R. Obodo,M. Akbari +12 more
TL;DR: In this article , the size and shape effects on materials at the nanoscale and their usage to test a set of quantum mechanics governed phenomena are discussed. But the focus of this paper is not on quantum mechanics.
Journal ArticleDOI
Recent advances in porous nanomaterials-based drug delivery systems for cancer immunotherapy
TL;DR: In this article , the authors summarized the recent progress of PNMs including inorganic, organic, and organic-inorganic hybrid ones for cancer immunotherapy and discussed the relevant challenges that urgently need to be addressed in clinical practice, coupled with corresponding solutions.
Journal ArticleDOI
Structural parameters of nanoparticles affecting their toxicity for biomedical applications: a review
TL;DR: In this article , the authors discuss the mechanisms of toxicity of nanoparticles and their interactions with living components by considering the impact of different physiochemical parameters such as size, shape, structure, agglomeration state, surface charge, wettability, dose, and substance type.
Journal ArticleDOI
Nanotechnology-aided diagnosis, treatment and prevention of leishmaniasis.
TL;DR: In this paper, the authors highlight the various nanotechnology-based approaches pursued until now to improve the detection of Leishmania species in biological samples, decrease the side effects and increase the efficacy of anti-leishmanial drugs, and induce enhanced immune responses, specifically focusing on the outcome of their preclinical and clinical evaluation.
Journal ArticleDOI
Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer
Yichao Bao,Jianning Zhai,Huarong Chen,Chi Chun Wong,Cong Liang,Yanqiang Ding,Dan Huang,Hongyan Gou,Danyu Chen,Yasi Pan,Wei Kang,Ka Fai To,Jun Yu +12 more
TL;DR: In this paper , the role of YTH N6-methyladenosine RNA binding protein 1 (YTHDF1) in colorectal cancer (CRC) time was investigated.
References
More filters
Journal ArticleDOI
Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
Michiru Nishita,Seung-Yeol Park,Tadashi Nishio,Koki Kamizaki,ZhiChao Wang,Kota Tamada,Toru Takumi,Ryuju Hashimoto,Hiroki Otani,Gregory J. Pazour,Victor W. Hsu,Yasuhiro Minami +11 more
TL;DR: It is found that intraflagellar transport 20 mediates the ability of Ror2 signaling to induce the invasiveness of tumors that lack primary cilia, and IFT20 regulates the nucleation of Golgi-derived microtubules by affecting the GM130-AKAP450 complex.
Journal ArticleDOI
Double-slit photoelectron interference in strong-field ionization of the neon dimer.
Maksim Kunitski,Nicolas Eicke,Pia Huber,Jonas Köhler,S. Zeller,J. Voigtsberger,Nikolai Schlott,K. Henrichs,H. Sann,Florian Trinter,Lothar Ph. H. Schmidt,Anton Kalinin,Markus Schöffler,Till Jahnke,Manfred Lein,Reinhard Dörner +15 more
TL;DR: The authors show the double-slit interference effect in the strong-field ionization of neon dimers by employing COLTRIMS method to record the momentum distribution of the photoelectrons in the molecular frame.
Journal ArticleDOI
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman,Axel Hauschild,Caroline Robert,John B. A. G. Haanen,Paolo A. Ascierto,James Larkin,Reinhard Dummer,Claus Garbe,Alessandro Testori,Michele Maio,David W. Hogg,Paul Lorigan,Céleste Lebbé,Thomas Jouary,Dirk Schadendorf,Antoni Ribas,Jeffrey A. Sosman,John M. Kirkwood,Brigitte Dréno,K. B. Nolop,Jiang Li,B. Nelson,Jeannie Hou,Richard J. Lee,Keith T. Flaherty,Grant A. McArthur +25 more
TL;DR: Vemurafenib produced improved rates of overall and progression-free survival in patients with previously untreated melanoma with the BRAF V600E mutation in a phase 3 randomized clinical trial.
Journal ArticleDOI
Principles of nanoparticle design for overcoming biological barriers to drug delivery
TL;DR: By successively addressing each of the biological barriers that a particle encounters upon intravenous administration, innovative design features can be rationally incorporated that will create a new generation of nanotherapeutics, realizing a paradigmatic shift in nanoparticle-based drug delivery.
Journal ArticleDOI
A New Initiative on Precision Medicine
TL;DR: A research initiative that aims to accelerate progress toward a new era of precision medicine, with a near-term focus on cancers and a longer-term aim to generate knowledge applicable to the whole range of health and disease.
Related Papers (5)
Nano based drug delivery systems: recent developments and future prospects
Jayanta Kumar Patra,Gitishree Das,Leonardo Fernandes Fraceto,Leonardo Fernandes Fraceto,Estefania Vangelie Ramos Campos,Estefania Vangelie Ramos Campos,Maria del Pilar Rodriguez-Torres,Laura Susana Acosta-Torres,Luis A. Diaz-Torres,Renato Grillo,Mallappa Kumara Swamy,Shivesh Sharma,Solomon Habtemariam,Han-Seung Shin +13 more